# A Pharmacokinetic Study of Aleglitazar in Healthy Chinese Volunteers

> **NCT01711775** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 16 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** aleglitazar

## Key facts

- **NCT ID:** NCT01711775
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01711775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01711775, "A Pharmacokinetic Study of Aleglitazar in Healthy Chinese Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01711775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*